AB Science receives notice of allowance for Unites States patent covering masitinib until 2040 in the treatment of sickle cell disease
14/04/2025 – AB Science today announced that the United States Patent Office has issued a Notice of Allowance for a patent relating to methods of treating sickle cell disease with its lead compound masitinib, based on preclinical data